rs1863704

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015690.5(STK36):​c.3008G>A​(p.Gly1003Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.354 in 1,613,918 control chromosomes in the GnomAD database, including 108,220 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 7488 hom., cov: 32)
Exomes 𝑓: 0.36 ( 100732 hom. )

Consequence

STK36
NM_015690.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.900

Publications

62 publications found
Variant links:
Genes affected
STK36 (HGNC:17209): (serine/threonine kinase 36) This gene encodes a member of the serine/threonine kinase family of enzymes. This family member is similar to a Drosophila protein that plays a key role in the Hedgehog signaling pathway. This human protein is a positive regulator of the GLI zinc-finger transcription factors. Knockout studies of the homologous mouse gene suggest that defects in this human gene may lead to congenital hydrocephalus, possibly due to a functional defect in motile cilia. Because Hedgehog signaling is frequently activated in certain kinds of gastrointestinal cancers, it has been suggested that this gene is a target for the treatment of these cancers. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2011]
STK36 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ciliary dyskinesia, primary, 46
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013133585).
BP6
Variant 2-218697952-G-A is Benign according to our data. Variant chr2-218697952-G-A is described in ClinVar as Benign. ClinVar VariationId is 403498.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.383 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STK36NM_015690.5 linkc.3008G>A p.Gly1003Asp missense_variant Exon 25 of 27 ENST00000295709.8 NP_056505.2 Q9NRP7-1A0A140VJW1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STK36ENST00000295709.8 linkc.3008G>A p.Gly1003Asp missense_variant Exon 25 of 27 1 NM_015690.5 ENSP00000295709.3 Q9NRP7-1

Frequencies

GnomAD3 genomes
AF:
0.278
AC:
42250
AN:
151954
Hom.:
7488
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0695
Gnomad AMI
AF:
0.325
Gnomad AMR
AF:
0.334
Gnomad ASJ
AF:
0.351
Gnomad EAS
AF:
0.0616
Gnomad SAS
AF:
0.270
Gnomad FIN
AF:
0.399
Gnomad MID
AF:
0.237
Gnomad NFE
AF:
0.387
Gnomad OTH
AF:
0.279
GnomAD2 exomes
AF:
0.319
AC:
80264
AN:
251388
AF XY:
0.325
show subpopulations
Gnomad AFR exome
AF:
0.0636
Gnomad AMR exome
AF:
0.341
Gnomad ASJ exome
AF:
0.343
Gnomad EAS exome
AF:
0.0606
Gnomad FIN exome
AF:
0.401
Gnomad NFE exome
AF:
0.382
Gnomad OTH exome
AF:
0.351
GnomAD4 exome
AF:
0.362
AC:
529721
AN:
1461846
Hom.:
100732
Cov.:
52
AF XY:
0.360
AC XY:
261769
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.0591
AC:
1979
AN:
33480
American (AMR)
AF:
0.341
AC:
15238
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.346
AC:
9033
AN:
26136
East Asian (EAS)
AF:
0.0629
AC:
2496
AN:
39700
South Asian (SAS)
AF:
0.279
AC:
24099
AN:
86258
European-Finnish (FIN)
AF:
0.397
AC:
21198
AN:
53392
Middle Eastern (MID)
AF:
0.272
AC:
1569
AN:
5768
European-Non Finnish (NFE)
AF:
0.390
AC:
433912
AN:
1111992
Other (OTH)
AF:
0.334
AC:
20197
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
20170
40341
60511
80682
100852
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13302
26604
39906
53208
66510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.278
AC:
42249
AN:
152072
Hom.:
7488
Cov.:
32
AF XY:
0.277
AC XY:
20556
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.0693
AC:
2879
AN:
41520
American (AMR)
AF:
0.333
AC:
5084
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.351
AC:
1219
AN:
3472
East Asian (EAS)
AF:
0.0622
AC:
322
AN:
5180
South Asian (SAS)
AF:
0.271
AC:
1307
AN:
4826
European-Finnish (FIN)
AF:
0.399
AC:
4209
AN:
10546
Middle Eastern (MID)
AF:
0.224
AC:
66
AN:
294
European-Non Finnish (NFE)
AF:
0.387
AC:
26276
AN:
67950
Other (OTH)
AF:
0.281
AC:
592
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1421
2841
4262
5682
7103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
436
872
1308
1744
2180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.344
Hom.:
33832
Bravo
AF:
0.266
TwinsUK
AF:
0.387
AC:
1434
ALSPAC
AF:
0.382
AC:
1473
ESP6500AA
AF:
0.0763
AC:
336
ESP6500EA
AF:
0.382
AC:
3284
ExAC
AF:
0.315
AC:
38187
Asia WGS
AF:
0.178
AC:
621
AN:
3478
EpiCase
AF:
0.380
EpiControl
AF:
0.378

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 06, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
9.7
DANN
Benign
0.28
DEOGEN2
Benign
0.12
T;.;T
Eigen
Benign
-0.87
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.064
N
LIST_S2
Benign
0.57
.;T;T
MetaRNN
Benign
0.0013
T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
2.0
M;.;M
PhyloP100
0.90
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.45
N;N;N
REVEL
Benign
0.18
Sift
Benign
0.52
T;T;T
Sift4G
Benign
0.62
T;T;T
Polyphen
0.18
B;P;B
Vest4
0.085
MPC
0.22
ClinPred
0.0022
T
GERP RS
2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.023
gMVP
0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1863704; hg19: chr2-219562675; COSMIC: COSV55325057; COSMIC: COSV55325057; API